Skip to content

About Us
Our Programs
News & Events
Investors
Contact Us

Search for:

Month: September 2020

Salarius Pharmaceuticals to Present at Upcoming Investor Conferences

Back

Salarius Pharmaceuticals to Present at Upcoming Investor Conferences

Read More

Search for:

Recent Posts

Salarius Pharmaceuticals Announces Closing of $6 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Salarius Pharmaceuticals Announces $6 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Salarius Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides a Business Update
FDA Removes Partial Clinical Hold on Salarius Pharmaceuticals’ Phase 1/2 Clinical Trial with Seclidemstat in Patients with Ewing Sarcoma
Salarius Pharmaceuticals Reports No Adverse Safety Signals from Two Good Laboratory Practice Toxicology Studies with its Targeted Protein Degrader SP-3164

Recent Comments

Archives

Categories

Uncategorized

Meta

Log in
Entries feed
Comments feed
WordPress.org

About Us
Our Programs
News & Events
Investors
Contact Us

Like Us on Facebook
Follow Us on Twitter
Connect on LinkedIn

© 2023 Salarius Pharmaceuticals, Inc. All Rights Reserved. Privacy and Terms of Use